Other Lupus News

September 29, 2015

Researchers have released a second set of results from the PROMISSE study showing that proteins measured in the mother’s blood can predict whether or not a woman with lupus is likely to experience serious complications during pregnancy.

September 28, 2015

Newly published study results showed improvement in lupus symptoms with the drug Rituxan® (rituximab), approved to treat rheumatoid arthritis.

September 10, 2015

NIAMS launched a new Spanish-language website that provides free health information on lupus and other conditions of the bones, joints, muscles and skin.

September 8, 2015

newly published study found that perceptions of racism in healthcare were more common in African-American (AA) patients than in white (WH) patients with systemic lupus erythematosus (SLE) and were associated with depression

September 8, 2015

A recently published study has shown an association between high levels of saturated fat in the blood and an increase in inflammatory induced tissue damage.  Published in the September 8 edition of Cell Reports, the study has potential implications for patients with immune disorders such as lupus.

August 31, 2015

Janus Biotherapeutics collaborating with pharmaceutical giant Roche to develop toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases – including lupus.

August 25, 2015

Early clinical trials suggest the investigational drug blisibimod may be safe and effective in treating lupus.

August 21, 2015

As reported by Lupus Daily News, a new study published in International Journal of Molecular Sciences shows that a standard lupus treatment can affect osteoporosis. 

August 20, 2015

 A new study finds that Benlysta, approved for lupus, may benefit patients with Sjögren’s.

August 19, 2015

As reported by Rheumatology Network, a new study published in American Journal of Public Health reports that unfair treatment by healthcare professionals is associated with disease damage among black women.

August 17, 2015

A new study suggests a target for developing a potential lupus treatment.

July 29, 2015

Learnings from two epratuzumab studies will inform progress in this complex autoimmune disease